Elsevier Announces New Brain Research Editor-In-Chief
New appointment aimed at maintaining the ethos, heritage and uniqueness of this pioneering journal in the field of Neuroscience
Oxford, 09 November, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce that Dr. Irwin B.Levitan has accepted the position of Editor-in-Chief of the journal Brain Research. He succeeds Dr. Floyd E. Bloom, who has served with distinction as an Editor of the journal since its inception in 1967 and, latterly since 2000, as its Editor-in-Chief. In his new role, Dr. Levitan will lead this popular multidisciplinary journal devoted to fundamental research in the brain sciences.
Dr. Levitan is Founding Chair of the Department of Neuroscience at Jefferson Medical College of Thomas Jefferson University in Philadelphia and has played an active part in the field of neuroscience for 35 years. He is also currently Director of the Farber Institute for Neurosciences at Jefferson and has received numerous awards and honors, including two successive NIH Jacob Javits Neuroscience Investigator Awards and two awards from the McKnight Endowment Fund for Neuroscience. He is a Fellow of the American Association for the Advancement of Science and has played prominent leadership roles in the Society for Neuroscience. Earlier this year, he was appointed President of the Association of Medical School Neuroscience Department Chairs.
Upon his appointment, Dr. Levitan commented, “I am excited to assume the role of Editor-in-Chief and I make a commitment to retain the tradition and unique characteristics of Brain Research to ensure the long term success of this great journal.”
Dr. Levitan has been Senior Editor for Neuroscience for the Encyclopedia of Life Sciences and a Reviewing Editor for the Journal of Neuroscience. In addition, he is co-editor of “Ion Channels and Receptors”, and a special issue of Neuropharmacology on “Potassium Channels”. He is also co-author of Neuromodulation: The Biochemical Control of Neuronal Excitability, and co-author of a widely-used textbook, The Neuron: Cell and Molecular Biology.
# # #
About Brain Research
Brain Research publishes papers reporting interdisciplinary investigations of nervous system structure, function and chemistry at all levels of resolution, from molecular to behavioral and social that are of general interest to the broad community of neuroscientists. Clinical investigations, Protocols (i.e. methods papers) and Reviews will also be considered for publication if they provide significant insight into the structure or function of the nervous system, the pathophysiology of a disease, or its treatment.
The journal has recently launched its new website and is sponsoring a satellite event on “The Emerging Neuroscience of Autism Spectrum Disorders: etiologic insights; treatment opportunities” prior to the 2010 Society for Neuroscience meeting in San Diego, 11-12th November 2010 www.brainresearch2010.com/.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.Media Contact
+ 44 1865 843654